EnteroMedics (ETRM) Spikes Despite Q4 Loss

EnteroMedics Inc (NASDAQ: ETRM) rose 14.4% to $7.36. EnteroMedics reported a Q4 loss of $2.65 per share on revenue of $141,900. Share volume was 4.3 million, compared to an all-day average of nine million